Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.845 USD | -0.36% | -2.56% | -38.86% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.86% | 188M | |
+11.83% | 116B | |
+12.13% | 106B | |
-9.14% | 23.89B | |
-2.71% | 21.58B | |
-11.00% | 18.96B | |
-40.50% | 16.96B | |
-14.23% | 16.33B | |
+6.67% | 14.14B | |
+30.68% | 12.02B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing